Literature DB >> 11827170

Functional specialization of CK2 isoforms and characterization of isoform-specific binding partners.

D W Litchfield1, D G Bosc, D A Canton, R B Saulnier, G Vilk, C Zhang.   

Abstract

In mammals, protein kinase CK2 has two isozymic forms of its catalytic subunit, designated CK2alpha and CK2alpha'. CK2alpha and CK2alpha' exhibit extensive similarity within their catalytic domains but have completely unrelated C-terminal sequences. To systematically examine the cellular functions of each CK2 isoform in mammalian cells, we have generated human osteosarcoma U2-OS cell lines with the expression of active or inactive versions of each CK2 isoform under the control of an inducible promoter. Examination of these cell lines provides evidence for functional specialization of CK2 isoforms at the cellular level in mammals with indications that CK2alpha' is involved in the control of proliferation and/or cell survival. To understand the molecular basis for functional differences between CK2alpha and CK2alpha', we have undertaken studies to identify proteins that interact specifically with each isoform of CK2 and could contribute to the regulation of their independent functions. A novel pleckstrin-homology domain containing protein, designated CK2-interacting protein 1 (i.e. CKIP-1) was isolated using the yeast two hybrid system as a protein that interacts with CK2alpha but not CK2alpha'. When expressed in cells as a fusion with green fluorescent protein, CKIP-1 localizes to the cell membrane and to the nucleus. In this study, we present evidence from deletion analysis of CKIP-1 suggesting that a C-terminal region containing a putative leucine zipper has a role in regulating its nuclear localization. Collectively, our data supports a model whereby CKIP-1 is a non-enzymatic regulator of CK2alpha that regulates the cellular functions of CK2alpha by targeting or anchoring CK2alpha to specific cellular localization or by functioning as an adapter to integrate CK2alpha-mediated signaling events with components of other signal transduction pathways.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11827170

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  58 in total

Review 1.  Protein kinase CK2 and its role in cellular proliferation, development and pathology.

Authors:  B Guerra; O G Issinger
Journal:  Electrophoresis       Date:  1999-02       Impact factor: 3.535

2.  Expression and regulation of protein kinase CK2 during the cell cycle.

Authors:  D G Bosc; B Lüscher; D W Litchfield
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

3.  Regulation of protein phosphatase 2A by direct interaction with casein kinase 2alpha.

Authors:  J K Hériché; F Lebrin; T Rabilloud; D Leroy; E M Chambaz; Y Goldberg
Journal:  Science       Date:  1997-05-09       Impact factor: 47.728

4.  Cytoplasmic and nuclear distribution of casein kinase II: characterization of the enzyme uptake by bovine adrenocortical nuclear preparation.

Authors:  O Filhol; C Cochet; E M Chambaz
Journal:  Biochemistry       Date:  1990-10-23       Impact factor: 3.162

5.  Casein kinase II. cDNA sequences, developmental expression, and tissue distribution of mRNAs for alpha, alpha', and beta subunits of the chicken enzyme.

Authors:  G Maridor; W Park; W Krek; E A Nigg
Journal:  J Biol Chem       Date:  1991-02-05       Impact factor: 5.157

6.  A DNA damage-induced p53 serine 392 kinase complex contains CK2, hSpt16, and SSRP1.

Authors:  D M Keller; X Zeng; Y Wang; Q H Zhang; M Kapoor; H Shu; R Goodman; G Lozano; Y Zhao; H Lu
Journal:  Mol Cell       Date:  2001-02       Impact factor: 17.970

7.  Stress-induced activation of protein kinase CK2 by direct interaction with p38 mitogen-activated protein kinase.

Authors:  M Sayed; S O Kim; B S Salh; O G Issinger; S L Pelech
Journal:  J Biol Chem       Date:  2000-06-02       Impact factor: 5.157

8.  Mapping of the interaction sites of the growth suppressor protein p53 with the regulatory beta-subunit of protein kinase CK2.

Authors:  K Appel; P Wagner; B Boldyreff; O G Issinger; M Montenarh
Journal:  Oncogene       Date:  1995-11-16       Impact factor: 9.867

9.  Globozoospermia in mice lacking the casein kinase II alpha' catalytic subunit.

Authors:  X Xu; P A Toselli; L D Russell; D C Seldin
Journal:  Nat Genet       Date:  1999-09       Impact factor: 38.330

10.  Regulation of casein kinase 2 by direct interaction with cell surface receptor CD5.

Authors:  C Raman; A Kuo; J Deshane; D W Litchfield; R P Kimberly
Journal:  J Biol Chem       Date:  1998-07-24       Impact factor: 5.157

View more
  16 in total

Review 1.  Protein kinase CK2: structure, regulation and role in cellular decisions of life and death.

Authors:  David W Litchfield
Journal:  Biochem J       Date:  2003-01-01       Impact factor: 3.857

2.  Cloning and purification of protein kinase CK2 recombinant alpha and beta subunits from the Mediterranean fly Ceratitis capitata.

Authors:  Sophia Kouyanou-Koutsoukou; Andrea Baier; Regina-Maria Kolaitis; Evanthia Maniatopoulou; Konstantina Thanopoulou; Ryszard Szyszka
Journal:  Mol Cell Biochem       Date:  2011-07-07       Impact factor: 3.396

3.  CK2 phosphorylation of an acidic Ser/Thr di-isoleucine motif in the Na+/H+ exchanger NHE5 isoform promotes association with beta-arrestin2 and endocytosis.

Authors:  Viktoria Lukashova; Elöd Z Szabó; Tushare Jinadasa; Alexei Mokhov; David W Litchfield; John Orlowski
Journal:  J Biol Chem       Date:  2011-02-04       Impact factor: 5.157

4.  Subtype-specific regulation of equilibrative nucleoside transporters by protein kinase CK2.

Authors:  Meaghan Stolk; Elizabeth Cooper; Greg Vilk; David W Litchfield; James R Hammond
Journal:  Biochem J       Date:  2005-03-01       Impact factor: 3.857

5.  Ability of CK2beta to selectively regulate cellular protein kinases.

Authors:  Birgitte B Olsen; Barbara Guerra
Journal:  Mol Cell Biochem       Date:  2008-06-17       Impact factor: 3.396

6.  The emerging CK2 interactome: insights into the regulation and functions of CK2.

Authors:  Laszlo Gyenis; David W Litchfield
Journal:  Mol Cell Biochem       Date:  2008-06-14       Impact factor: 3.396

Review 7.  Protein kinase CK2: a potential therapeutic target for diverse human diseases.

Authors:  Christian Borgo; Claudio D'Amore; Stefania Sarno; Mauro Salvi; Maria Ruzzene
Journal:  Signal Transduct Target Ther       Date:  2021-05-17

8.  Occludin S408 phosphorylation regulates tight junction protein interactions and barrier function.

Authors:  David R Raleigh; Devin M Boe; Dan Yu; Christopher R Weber; Amanda M Marchiando; Emily M Bradford; Yingmin Wang; Licheng Wu; Eveline E Schneeberger; Le Shen; Jerrold R Turner
Journal:  J Cell Biol       Date:  2011-05-02       Impact factor: 10.539

9.  CK2 Secreted by Leishmania braziliensis Mediates Macrophage Association Invasion: A Comparative Study between Virulent and Avirulent Promastigotes.

Authors:  Ana Madeira Brito Zylbersztejn; Carlos Gustavo Vieira de Morais; Ana Karina Castro Lima; Joyce Eliza de Oliveira Souza; Angela Hampshire Lopes; Sílvia Amaral Gonçalves Da-Silva; Mário Alberto Cardoso Silva-Neto; Patrícia Maria Lourenço Dutra
Journal:  Biomed Res Int       Date:  2015-05-18       Impact factor: 3.411

10.  Cancer-type dependent expression of CK2 transcripts.

Authors:  Melissa M J Chua; Migi Lee; Isabel Dominguez
Journal:  PLoS One       Date:  2017-12-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.